VENNLIFESCIENCES.COM: Keyword Density Checker

Total words: 3813 | 2-word phrases: 1001 | 3-word phrases: 1133 | 4-word phrases: 1163

PAGE INFO

Title	Try to keep the title under 60 characters (64 characters) Venn Life Sciences - Drug Development Consultancy & Services
Description	Try to keep the meta description between 50 - 160 characters (145 characters) An Integrated Drug Development Partner offering a unique combination of drug development expertise, clinical trial design and execution services.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (52 characters) Your drug development partner. From start to finish.

#	Keyword	Frequency	Density
1	venn life sciences	9	0.79%
2	of the drug	4	0.35%
3	the drug development	4	0.35%
4	statistics study design	3	0.26%
5	of mabel calculation	2	0.18%
6	with venn life	2	0.18%
7	over 25 years	2	0.18%
8	support of venn	2	0.18%
9	order to ensure	2	0.18%
10	drug development journey	2	0.18%
11	stages of the	2	0.18%
12	human dose prediction	2	0.18%
13	dose prediction including	2	0.18%
14	prediction including designing	2	0.18%
15	including designing of	2	0.18%
16	designing of preclinical	2	0.18%
17	in drug development	2	0.18%
18	experiments and subsequent	2	0.18%
19	and subsequent execution	2	0.18%
20	subsequent execution of	2	0.18%
21	execution of mabel	2	0.18%
22	“we have been	2	0.18%
23	pivotal role in	2	0.18%
24	role in obtaining	2	0.18%
25	in obtaining tga’s	2	0.18%
26	about us a	2	0.18%
27	obtaining tga’s approval	2	0.18%
28	tga’s approval of	2	0.18%
29	approval of client’s	2	0.18%
30	plan that was	2	0.18%

#	Keyword	Frequency	Density
1	of the drug development	3	0.26%
2	this enables us to	2	0.17%
3	human dose prediction including	2	0.17%
4	in drug development a	2	0.17%
5	subsequent execution of mabel	2	0.17%
6	and subsequent execution of	2	0.17%
7	experiments and subsequent execution	2	0.17%
8	pivotal role in obtaining	2	0.17%
9	including designing of preclinical	2	0.17%
10	prediction including designing of	2	0.17%
11	dose prediction including designing	2	0.17%
12	the drug development journey	2	0.17%
13	clinical trial design and	2	0.17%
14	stages of the drug	2	0.17%
15	role in obtaining tga’s	2	0.17%
16	in obtaining tga’s approval	2	0.17%
17	plan and execute drug	2	0.17%
18	create plan and execute	2	0.17%
19	obtaining tga’s approval of	2	0.17%
20	with venn life sciences	2	0.17%
21	tga’s approval of client’s	2	0.17%
22	execution of mabel calculation	2	0.17%
23	data to characterize its	1	0.09%
24	analyzing the clinical trial	1	0.09%
25	its pharmacokinetic properties congratulations	1	0.09%
26	to characterize its pharmacokinetic	1	0.09%
27	characterize its pharmacokinetic properties	1	0.09%
28	pritelivir in analyzing the	1	0.09%
29	pharmacokinetic properties congratulations to	1	0.09%
30	the aicuris team for	1	0.09%
31	aicuris team for the	1	0.09%
32	team for the publication	1	0.09%
33	for the publication of	1	0.09%
34	the publication of part	1	0.09%
35	publication of part of	1	0.09%
36	of part of this	1	0.09%
37	in analyzing the clinical	1	0.09%
38	with the development of	1	0.09%
39	of pritelivir in analyzing	1	0.09%
40	of venn’s cmc nonclinical	1	0.09%

#	URL	Whois	Check
1	https://twitter.com/VennLifeScience	Whois	twitter.com
2	https://www.linkedin.com/company/venn-life-sciences/	Whois	linkedin.com
3	https://polaris.brighterir.com/public/hvivo/news/rns/story/rggld0r	Whois	brighterir.com
4	https://polaris.brighterir.com/public/hvivo/news/rns/story/rnk452r	Whois	brighterir.com
5	https://www.youtube.com/watch?v=4zMOrirIqRs	Whois	youtube.com
6	https://polaris.brighterir.com/public/hvivo/news/rns/story/w9j9mdx	Whois	brighterir.com
7	https://polaris.brighterir.com/public/hvivo/news/rns/story/w3nd03r	Whois	brighterir.com
8	https://hvivo.com/	Whois	hvivo.com
9	https://www.openorphan.com/	Whois	openorphan.com
10	https://nephew.media	Whois	nephew.media
11	https://twitter.com/VennLifeScience	Whois	twitter.com
12	https://www.linkedin.com/company/venn-life-sciences/	Whois	linkedin.com